Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Mavenir and O2 Telefónica Germany Strengthen Partnership with Multi-Year IMS Contract Extension for Cloud-Native IMS Services
-
AVANTE ANNOUNCES 21% REVENUE GROWTH AND 74% ADJUSTED EBITDA GROWTH FOR Q3 FISCAL 2025
-
Bio Usawa Appoints Dr. Patrick Lukulay as Chief Operating Officer
-
Verisk Reports Fourth-Quarter 2024 and Full-Year 2024 Financial Results
-
CryoMass Announces Sale of CryoSift Separator™ and License of Its Cryogenic Refinement Technology in Oklahoma Market
-
Form 8.3 - [LEARNING TECHNOLOGIES GROUP PLC - 25 02 2025] - (CGWL)
-
Goliath Resources Presenting At Metals Investors Forum (MIF) February 28ᵗʰ - March 1ˢᵗ And PDAC 2025, March 2ⁿᵈ - 5ᵗʰ, Booth # 3234
-
Form 8.3 - [ALLIANCE PHARMA PLC - 25 02 2025] - (CGWL)
-
Kraig Biocraft Laboratories Achieves Breakthrough In Recombinant Spider Silk Design Complexity
-
Dycom Announces Authorization of a New $150 Million Stock Repurchase Program
-
Avista Corp. Reports 2024 Results and Initiates 2025 Earnings Guidance
-
Astec Reports Record Fourth Quarter, Full Year 2024 Results
-
Sprott Announces Year Ended 2024 Results
-
Tenapanor Approved in China for Hyperphosphatemia
-
Fury Gold Mines Limited to Acquire Quebec Precious Metals Corporation
-
Metsera to Present at TD Cowen’s 45th Annual Health Care Conference
-
Chicago Atlantic Real Estate Finance Schedules Fourth Quarter 2024 Earnings Release and Conference Call Date
-
Odronextamab BLA Accepted for FDA Review for the Treatment of Relapsed/Refractory Follicular Lymphoma
-
Antitrust, Intellectual Property, Digital Platforms and International Business Expert Professor Daniel Spulber Affiliates with Compass Lexecon
-
Metallurgical Test Work confirms > 95% Lithium Extraction from Acid Leach on High-Grade Mineralization Samples from Bonnie Claire
-
Rocky Shore Stakes Gold-Bearing Appleton Fault Corridor at Gold Anchor Project
-
Madrigal Pharmaceuticals Reports Fourth-Quarter and Full-Year 2024 Financial Results and Announces New Two-Year Data Demonstrating Potential Benefit of Rezdiffra™ (resmetirom) in Patients with Compe
-
EyePoint to Report Fourth Quarter and Full-Year 2024 Financial Results on March 5, 2025
-
Kymera Therapeutics to Participate in Upcoming March Investor Conferences
-
Abaxx Singapore and ZEMA Global Data Announce Market Data Partnership
-
Wallbridge Mining Provides Corporate Update
-
Microbix Announces Issuance of Stock Options
-
Wugen Announces Appointment of Jim Faulkner, Ph.D., as Chief Technology Officer
-
Forsys Reports Additional Interim Drilling Results from Norasa
-
Opthea Completes Drug Product PPQ Campaign
-
Cognition Therapeutics Successfully Passes Pre-defined Futility Analysis of Phase 2 Study of Oral Zervimesine (CT1812) in Geographic Atrophy
-
Dianthus Therapeutics to Participate in Two Upcoming Investor Conferences
-
CytoSorbents to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
-
Talisker Receives Positive Ore Sorting Results for the Bralorne Gold Project
-
Tilray Brands Announces 420 Concert with Multi-Platinum Artist Don Toliver
-
Lantheus Reports Fourth Quarter and Full Year 2024 Financial Performance
-
Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Business Update
-
The Vita Coco Company Reports Strong Fourth Quarter and Full Year 2024 Financial Results
-
Boundless Bio to Participate in the Leerink Global Healthcare Conference
-
Axsome Therapeutics to Participate in Upcoming Investor Conferences
-
Aquestive Therapeutics to Participate in Two Upcoming Conferences in March
-
Photronics Reports First Quarter Fiscal 2025 Results
-
Winnebago Industries to Present at the 46th Annual Raymond James Institutional Investors Conference
-
Village Farms International to Report Q4 and Full Year 2024 Results on March 13, 2025
-
REMINDER: Stella-Jones Will Hold a Conference Call to Discuss Its Fourth Quarter Results
-
Dycom Industries, Inc. Reports Fiscal 2025 Fourth Quarter and Annual Results and Provides Outlook
-
Kamada to Announce Fourth Quarter and Fiscal Year 2024 Financial Results on March 5, 2025
-
Perspective Therapeutics to Present at Upcoming March Investor Conferences
-
WEBTOON Entertainment Inc. to Participate in Upcoming Investor Conferences
-
Eyenovia Regains Compliance with All Nasdaq Continued Listing Requirements
